These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Opioid agonist-antagonist drugs in acute and chronic pain states. Hoskin PJ; Hanks GW Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441 [TBL] [Abstract][Full Text] [Related]
5. Disposition of narcotics and narcotic antagonists. Inturrisi CE Ann N Y Acad Sci; 1976; 281():273-87. PubMed ID: 828465 [No Abstract] [Full Text] [Related]
6. Recent progress in research on narcotic antagonists. Archer S; Michne WF Prog Drug Res; 1976; 20():45-100. PubMed ID: 189354 [No Abstract] [Full Text] [Related]
7. Opioid agonist/antagonists in general anaesthesia. Wilkinson DJ Br J Hosp Med; 1987 Aug; 38(2):130-3. PubMed ID: 2888499 [TBL] [Abstract][Full Text] [Related]
8. Clinical observations of agonist-antagonist analgesic dependence. Peachey JE Drug Alcohol Depend; 1987 Dec; 20(4):347-65. PubMed ID: 2894289 [TBL] [Abstract][Full Text] [Related]
9. Sulfation of buprenorphine, pentazocine, and naloxone by human cytosolic sulfotransferases. Kurogi K; Chen M; Lee Y; Shi B; Yan T; Liu MY; Sakakibara Y; Suiko M; Liu MC Drug Metab Lett; 2012 Jun; 6(2):109-15. PubMed ID: 22946908 [TBL] [Abstract][Full Text] [Related]
10. Using agonist-antagonist opioids and antagonist drugs. Pasero C; McCaffery M Am J Nurs; 1999 Jan; 99(1 Pt 1):20, 23. PubMed ID: 9932048 [No Abstract] [Full Text] [Related]
11. Drug discrimination in human postaddicts: agonist-antagonist opioids. Preston KL; Bigelow GE; Bickel WK; Liebson IA J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Full ยต-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence. van Niel JC; Schneider J; Tzschentke TM Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867 [TBL] [Abstract][Full Text] [Related]
13. Historical introduction and review of chemistry. Harris LS; May EL Drug Alcohol Depend; 1985 Feb; 14(3-4):227-32. PubMed ID: 3888575 [TBL] [Abstract][Full Text] [Related]
14. Drug discrimination in human post-addicts: agonist/antagonist opioids. Preston K; Bigelow G; Bickel W; Liebson I NIDA Res Monogr; 1988; 81():209-15. PubMed ID: 2457160 [No Abstract] [Full Text] [Related]
15. [A clinical-experimental study of narcotic properties of opiate receptor agonists-antagonists and experience in their use in drug addiction practice]. Sofronov AG; Kuz'min AV; Pchelintsev MV; Belogurov SB Anesteziol Reanimatol; 1994; (4):13-5. PubMed ID: 7802310 [TBL] [Abstract][Full Text] [Related]
16. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. King CD; Rios GR; Green MD; MacKenzie PI; Tephly TR Drug Metab Dispos; 1997 Feb; 25(2):251-5. PubMed ID: 9029056 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of antagonists of narcotic-induced respiratory depression. A brief review. Bowdle TA Acute Care; 1988; 12 Suppl 1():70-6. PubMed ID: 3278495 [TBL] [Abstract][Full Text] [Related]
18. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure. Preston KL; Bigelow GE J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929 [TBL] [Abstract][Full Text] [Related]
19. Acidosis lowers in-vivo potency of narcotics and narcotic antagonists and can even abolish narcotic antagonist activity. Kaufman JJ Lancet; 1982 Mar; 1(8271):559-60. PubMed ID: 6120409 [No Abstract] [Full Text] [Related]